Local suppression of pro-inflammatory cytokines and the effects in BMP-2-induced bone regeneration

Biomaterials

Volumn 33, Issue 1, 2012, Pages 304-316

  Ratanavaraporn, Juthamas ^a   Furuya, Hiroyuki ^a   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Bone morphogenic protein 2 (BMP 2); Bone regeneration; Controlled release; Inflammation suppression; Pro inflammatory cytokines; Triptolide

Indexed keywords

BONE REGENERATION; CONTROLLED RELEASE; CYTOKINES; INFLAMMATION SUPPRESSION; MORPHOGENIC; TRIPTOLIDE;

BONE; DEFECTS; MACROPHAGES; MICELLES; PATHOLOGY; PHOSPHATASES;

HYDROGELS;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CYTOKINE; GELATIN; INTERLEUKIN 10; INTERLEUKIN 6; TRIPTOLIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HYDROGEL; INFLAMMATION; MACROPHAGE; MICELLE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELL LINE; CYTOKINES; DITERPENES; EPOXY COMPOUNDS; GELATIN; HYDROGELS; INFLAMMATION; MALE; MICE; MICELLES; PHENANTHRENES; RATS; RATS, WISTAR;

RATTUS;

EID: 82855165021     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.09.050     Document Type: Article

References (63)

1. Wan C., He Q., Li G. Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model. J Orthop Res 2006, 24:610-618.
2. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., Robey P.G. Circulating skeletal stem cells. J Cell Biol 2001, 153:1133-1139.
3. Rundle C.H., Wang H., Yu H., Chadwick R.B., Davis E.I., Wergedal J.E., et al. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone 2006, 38:521-529.
4. Cooper P.R., Takahashi Y., Graham L.W., Simon S., Imazato S., Smith A.J. Inflammation-regeneration interplay in the dentine-pulp complex. J Dent 2010, 38:687-697.
5. Goertz O., Ring A., Buschhaus B., Hirsch T., Daigeler A., Steinstraesser L., et al. Influence of anti-inflammatory and vasoactive drugs on microcirculation and angiogenesis after burn in mice. Burns 2011, 37:656-664.
6. Corsetti G., Antona G.D., Dioguardi F.S., Rezzani R. Topical application of dressing with amino acids improves cutaneous wound healing in aged rats. Acta Histochem 2010, 112:497-507.
7. Mountziaris P.M., Mikos A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B 2008, 14:179-186.
8. Gerstenfeld L.C., Cho T.J., Kon T., Aizawa T., Tsay A., Fitch J., et al. Impaired fracture healing in the absence of TNF-a signaling: the role of TNF-a in endochondral cartilage resorption. J Bone Miner Res 2003, 18:1584-1592.
9. Lacey D.C., Simmons P.J., Graves S.E., Hamilton J.A. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis Cartilage 2009, 17:735-742.
10. Wu G., Liu Y., Iizuka T., Hunziker E.B. The effect of a slow mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds. Biomaterials 2010, 31:7485-7493.
11. Kim S.E., Song S.H., Yun Y.P., Choi B.J., Kwon I.K., Bae M.S., et al. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials 2011, 32:366-373.
12. Nyangoga H., Aguado E., Goyenvalle E., Baslé M.F., Chappard D. A non-steroidal anti-inflammatory drug (ketoprofen) does not delay b-TCP bone graft healing. Acta Biomater 2010, 6:3310-3317.
13. Penga L.H., Ko C.H., Siu S.W., Koon C.M., Yue G.L., Cheng W.H., et al. In vitro & in vivo assessment of a herbal formula used topically for bone fracture treatment. J Ethnopharmacol 2010, 131:282-289.
14. Qiu D., Zhao G., Aoki Y., Shi L., Uyei A., Nazarian S., et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-KappaB transcriptional activation. J Biol Chem 1999, 274:13443-13450.
15. Krakauer T., Chen X., Howard O.M., Young H.A. Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T cell proliferation and production of cytokines and chemokines. Immunopharm Immunot 2005, 27:53-66.
16. Yang Y., Liu Z., Tolosa E., Yang J., Li L. Triptolide induces apoptotic death of T lymphocyte. Immunopharmacology 1998, 40:139-149.
17. Liu Q., Chen T., Chen G., Li N., Wang J., Ma P., et al. Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation. Biochem Bioph Res Co 2006, 345:1122-1130.
18. Wang J., Xu R., Jin R., Chen Z., Fidler J.M. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine. Transplantation 2000, 70:447-455.
19. Fidler J.M., Ku G.Y., Piazza D., Xu R., Jin R., Chen Z. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract. Transplantation 2002, 74:445-457.
20. Zheng J. Screening of active anti-inflammatory, immunosuppressive and antifertility components of Tripterygium wilfordii: III. A comparison of the anti-inflammatory and immunosuppressive activities of 7 diterpene lactone epoxide compounds in vivo. Acta Acad Med Sin 1991, 13:391-397.
21. Gu W.Z., Chen R., Brandwein S., McAlpine J., Burres N. Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: triptolide and tripdiolide. Int J Immunopharmacol 1995, 17:351-356.
22. Wei X., Gong J., Zhu J., Wang P., Li N., Zhu W., et al. The suppressive effect of triptolide on chronic colitis and TNF-α/TNFR2 signal pathway in interleukin-10 deficient mice. Clin Immunol 2008, 129:211-218.
23. Zhu K.J., Shen Q.Y., Cheng H., Mao X.H., Lao L.M., Hao G.L. Triptolide affects the differentiation, maturation and function of human dendritic cells. Int J Immunopharmacol 2005, 5:1415-1426.
24. Liu Q., Chen T., Chen G., Shu X., Sun A., Ma P., et al. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-κB pathways. Mol Immunol 2007, 44:2686-2696.
25. Yamamoto M., Takahashi Y., Tabata Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 2003, 24:4375-4383.
26. Kimura Y., Miyazaki N., Hayashi N., Otsuru S., Tamai K., Kaneda Y., et al. Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Tissue Eng Part A 2010, 16:1263-1270.
27. Ratanavaraporn J., Furuya H., Kohara H., Tabata Y. Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials 2011, 32:2797-2811.
28. Tabata Y., Hijikata S., Ikada Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J Control Release 1994, 31:189-199.
29. Yamamoto M., Tabata Y., Hong L., Miyamoto S., Hashimoto N., Ikada Y. Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel. J Control Release 2000, 64:133-142.
30. Kido Y., Jo J., Tabata Y. A gene transfection for rat mesenchymal stromal cells in biodegradable gelatin scaffolds containing cationized polysaccharides. Biomaterials 2011, 32:919-925.
31. Nakamura M., Jo J., Tabata Y., Ishikawa O. Controlled delivery of T-box 21 siRNA ameliorates autoimmune alopecia (alopecia areata) in C3H/HeJ mouse model. Am J Pathol 2008, 172:650-658.
32. Konishi M., Tabata Y., Kariya M., Hosseinkhani H., Suzuki A., Fukuhara K., et al. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release 2005, 103:7-19.
33. Tanigo T., Takaoka R., Tabata Y. Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration. J Control Release 2010, 143:201-206.
34. Ozeki M., Tabata Y. In vivo degradability of hydrogels prepared from different gelatins by various cross-linking methods. J Biomater Sci Polym Ed 2005, 16:549-561.
35. Kimura Y., Tabata Y. Controlled release of stromal cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed 2010, 21:37-51.
36. Takahashi Y., Yamamoto M., Tabata Y. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and β-tricalcium phosphate. Biomaterials 2005, 26:3587-3596.
37. Virk M.S., Conduah A., Park S.H., Liu N., Sugiyama O., Cuomo A., et al. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone 2008, 42:921-931.
38. Hollinger J.O., Kleinschmidt J.C. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg 1990, 1:60-68.
39. Tang B., Matsuda T., Akira S., Nagata N., Ikehara S., Hirano T., et al. Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol 1991, 3:273-278.
40. Chen H., Chang X., Weng T., Zhao X., Gao Z., Yang Y., et al. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release 2004, 98:427-436.
41. Liu M., Dong J., Yang Y., Yang X., Xu H. Anti-inflammatory effects of triptolide loaded poly(d, l-lactic acid) nanoparticles on adjuvant-induced arthritis in rats. J Ethnopharmacol 2005, 97:219-225.
42. Lin N., Liu C., Xiao C., Jia H., Imada K., Wu H., et al. Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice. Biochem Pharmacol 2007, 73:136-146.
43. Lee J.S., Bae J.W., Joung Y.K., Lee S.J., Han D.K., Park K.D. Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle. Int J Pharm 2008, 346:57-63.
44. Holland T.A., Tabata Y., Mikos A.G. Dual growth factor delivery from degradable oligo (poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 2005, 10:111-125.
45. Hoyle G.W., Hoyle C.I., Chen J., Chang W., Williams R.W., Rando R.J. Identification of triptolide, a natural diterpenoid compound, as an inhibitor of lung inflammation. Am J Physiol Lung Cell Mol Physiol 2010, 298:L830-L836.
46. Yang S.X., Xie S.S., Gao H.L., Ma D.L., Long Z.Z. Triptolide suppresses T-lymphocyte proliferation by inhibiting interleukin-2 receptor expression, but spares interleukin-2 production and mRNA expression. Int J Immunopharmacol 1994, 16:895-904.
47. Jin Y., Chen Q., Shi X., Lu Z., Cheng C., Lai Y., et al. Activity of triptolide against human mast cells harboring the kinase domain mutant KIT. Cancer Sci 2009, 100:1335-1343.
48. Ho J.C., Tipoe G., Zheng L., Leung T.M., Tsang K.W.T., Shum D.K.Y., et al. In vitro study of regulation of IL-6 production in bronchiectasis. Resp Med 2004, 98:334-341.
49. Howard M., O'Garra A. Biological properties of interleukin 10. J Clin Immunol 1992, 12:239-247.
50. Lesur I., Textoris J., Loriod B., Courbon C., Garcia S., Leone M. Gene expression profiles characterize inflammation stages in the acute lung injury in mice. Plos One 2010, 5:1-14.
51. Okamoto T., Saito T., Tabata Y., Uemoto S. Immunological tolerance in a mouse model of immune-mediated liver injury induced by 16,16 dimethyl PGE2 and PGE2-containing nanoscale hydrogels. Biomaterials 2011, 32:4925-4935.
52. Jun L.Y., Jie J., Gui W.Y. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells. Leuk Res 2005, 29:99-105.
53. Dai Y.Q., Jin D.Z., Zhu X.Z., Lei D.L. Triptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytes. Neurosci Res 2006, 55:154-160.
54. Karin M., Greten F.R. NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev 2005, 5:749-759.
55. Yong-tang W., Xiu-min L., Ying Y., Yan-hong Y., Jie G. Expression of NF-κB in schwann cells and its effect on motor neuron apoptosis in spinal cord following sciatic nerves injury in rats. J Med Colleges PLA 2007, 22:92-96.
56. Mukaino M., Nakamura M., Yamada O., Okada S., Morikawa S., Renault-Mihara F., et al. Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol 2010, 224:403-414.
57. Xu L., Pan J., Chen Q., Yu Q., Chen H., Xu H., et al. In vivo evaluation of the safety of triptolide-loaded hydrogel-thickened microemulsion. Food Chem Toxicol 2008, 46:3792-3799.
58. Bai S., Thummel R., Godwin A.R., Nagase H., Itoh Y., Li L., et al. Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2. Matrix Biol 2005, 24:247-260.
59. Knittel T., Mehde M., Grundmann A., Saile B., Scharf J.G., Ramadori G. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol 2000, 113:443-453.
60. Katoh N., Ito T. Inhibition by dexamethasone of interleukin-ll3 and interleukin-6 expression in alveolar macrophages from cows. Res Vet Sci 1995, 59:41-44.
61. Mountziaris P.M., Tzouanas S.N., Mikos A.G. Dose effect of tumor necrosis factor-α on in vitro osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds. Biomaterials 2010, 31:1666-1675.
62. Giulietti A., Etten E.V., Overbergh L., Stoffels K., Bouillon R., Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile: 1,25-Dihydroxyvitamin D3 works as anti-inflammatory. Diabetes Res Clin Pr 2007, 77:47-57.
63. Suzuki Y., Ichiyama T., Ohsaki A., Hasegawa S., Shiraishi M., Furukawa S. Anti-inflammatory effect of 1α,25-dihydroxyvitamin D3 in human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease. J Steroid Biochem 2009, 113:134-138.